Welcome to Cellogen Therapeutics

We at Cellogen Therapeutics use advanced cellular engineering methods and gene therapy-based approaches to find curative treatment for various hematological malignancies, solid tumors, hemoglobinopathies and various other human ailments.

We have conceptualised and designed state-of-the-art third and fourth generation CAR constructs (CAR T-cell therapies)  for blood cancers such as leukaemia, lymphoma which have shown very encouraging results in pre-clinical models.

Know More  

CAR T Cells

Our company is at the forefront of developing cutting-edge bi-specific, 3rd and 4th generation CAR T-cell therapies, which represent a significant advancement in cancer immunotherapy. Unlikethe monospecific 2nd generation CAR currently available for clinical use, these CARs are engineered for enhanced precision and potency.

Bi targeting two different antigens CD19 and 20 simultaneously, we have tried to reduce the risk of antigen escape mediated relapses.

Know More  

Gene Manipulation

We are pioneering advanced cellular therapies to revolutionize treatment for these disorders. Through gene-editing techniques such as CRISPR and stem cell transplantation, cellular therapies target the root cause of the disease. By reprogramming or replacing faulty hematopoietic stem cells, these therapies enable the body to produce healthy, functional red blood cells, offering a potential cure rather than mere symptom management.

Know More  

Blog

See Our Research Blogs

How we can treat Sickle Cell Disease, Thalassemia and other Blood Disorders with Gene manipulation

Sickle cell disease (SCD) and thalassemia are among the most common inherited blood disorders, affecting millions of people globally.

Team Cellogen | 3 mins read

CAR T-Cell Therapy: A New Frontier in Treating Solid Tumors

Chimeric Antigen Receptor (CAR) T-cell therapy has revolutionized treatment for hematologic malignancies like leukemia and lymphoma.

Team Cellogen | 3 mins read

CRISPR-Cas is revolutionising Blood Cancer Treatment

Blood cancers, including leukemia, lymphoma, and myeloma, have long presented challenges to both patients and medical professionals

Team Cellogen | 3 mins read

Indigenous CRISPR-Cas: Paving the Way for Affordable Cancer Treatment in India

Cancer remains a significant public health challenge in India, with the rising cost of treatment placing an immense burden on patients and their families

Team Cellogen | 3 mins read

PARTNERS

Our Associates and Partners